Coherus Oncology

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CHRS and other ETFs, options, and stocks.

About CHRS

Coherus Oncology, Inc. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of biosimilar therapeutics. Its products include UDENYCA and LOQTORZI.

CEO

Denny M. Lanfear

CEODenny M. Lanfear

Employees

228

Employees228

Headquarters

Redwood City, California

HeadquartersRedwood City, California

Founded

2010

Founded2010

Employees

228

Employees228

CHRS Key Statistics

Market cap

155.60M

Market cap155.60M

Price-Earnings ratio

-0.92

Price-Earnings ratio-0.92

Dividend yield

—

Dividend yield—

Average volume

1.29M

Average volume1.29M

High today

$1.39

High today$1.39

Low today

$1.26

Low today$1.26

Open price

$1.33

Open price$1.33

Volume

2.46M

Volume2.46M

52 Week high

$2.43

52 Week high$2.43

52 Week low

$0.6603

52 Week low$0.6603

CHRS News

TipRanks 8h

Coherus Biosciences upgraded to Buy from Neutral at Roth Capital

Roth Capital upgraded Coherus Biosciences (CHRS) to Buy from Neutral. Published first on TheFly – the ultimate source for real-time, market-moving breaking fin...

Analyst ratings

67%

of 6 ratings

Buy

66.7%

Hold

33.3%

Sell

People also own

Based on the portfolios of people who own CHRS. This list is generated using Robinhood data, and it’s not a recommendation.